These ASX shares could rise 17% to 25%

Analysts think these buy-rated shares could deliver market-beating returns.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market may be near a record high but that doesn't mean there aren't ASX shares out there with the potential to generate big returns.

Let's take a look at three ASX shares that could rise 17% to 25% according to analysts. They are as follows:

Three people in a corporate office pour over a tablet, ready to invest.

Image source: Getty Images

Endeavour Group Ltd (ASX: EDV)

Analysts at Goldman Sachs think that this drinks giant is seriously undervalued by the market at present.

The broker highlights that the BWS and Dan Murphy's owner is one of the most attractively priced stocks in the consumer sector. It said:

EDV is currently trading at FY25 P/E of 18x vs FY24-27e EPS CAGR of 6%, while the implied EV/EBIT on Hotels is 3.6x (assuming Retail EV/EBIT of 15x), attractive amongst our Consumer coverage.

Goldman has a buy rating and $6.20 price target on its shares. This implies potential upside of 26% for investors from current levels. In addition, a dividend yield of 4.5% is expected by the broker.

Life360 Inc (ASX: 360)

The team at Bell Potter continues to believe that this high-flying ASX tech share can keep rising.

It is bullish on the location technology company and believes it is destined to deliver strong top line growth for at least the next three years. It said:

We continue to forecast strong top line revenue growth in 2024, 2025 and 2026 of 22%, 20% and 17% and positive statutory EBITDA and NPAT in 2025 and beyond.

Last week, Bell Potter put a buy rating and $22.50 price target on Life360's shares. This suggests that they could rise 17.5% over the next 12 months.

Qualitas Ltd (ASX: QAL)

Morgans thinks that this alternative real estate investment manager could be a top ASX share to buy.

It was pleased with its performance in FY 2024 and is positive on its outlook. In respect to the latter, the broker said:

FY25 guidance for NPBT of $49-$55m reflects growth of c.26% to 41% (vs pcp), with base management fees and balance sheet co-investments to deliver the bulk of the growth. Management commented that its current cash balance should be sufficient to see it reach the aspirational target of $18bn FUM by FY28. Deployments should continue to grow, albeit at a slower pace, with the proportion of net to gross loans likely to remain similar. […] QAL is well-positioned to increase market share in debt funding for affordable multi-unit metro developments.

Morgans has an add rating and $3.20 price target on its shares. This implies potential upside of 25% for investors from current levels.

Motley Fool contributor James Mickleboro has positions in Endeavour Group and Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Life360. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »